As illustrated by the circos plots (Figure 3a), DNA‐Seq of the cfDNA samples detected several cancer‐related genomic alterations and confirmed the amplification of ERBB2 (on chromosome 17) of patients PMB 2.8 and PMB 2.36, in line with diagnostic tissue biopsy in situ assessment (Table S1). Here, ERBB2 is linked to cancer.